GDRX
BILL

Wagner Scott

Known title: DirectorCIK: 0001342655

Wagner Scott's purchase track record

How the stock did after each of Wagner Scott's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.

Purchases measured
3
of 3 since November 14, 2023
Stock higher 6 months later
100%
3 months: 100%
Median 6-month return
+21.8%
3 months: +10.4%
Beat the S&P 500
67%
median +5.3% vs. index
PurchaseStockAmount3 months6 months
11/28/2023GDRX$305K+10.4%+21.8%
11/16/2023GDRX$677K+29.4%+55.0%
11/14/2023BILL$508K+8.6%+1.6%

Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

September 7, 2026

GoodRx Expands Savings Offering With Companion Family Plan for Pets and People. GoodRx has launched a Companion Family Plan that extends its healthcare savings to pets as well as household members. The company is positioning the new offering as a way to bring prescription and care discounts to the entire family, including animals, broadening the appeal of its platform. Separately, a recent market analysis listed GoodRx among stocks viewed as having mixed momentum. The company is already trading near a well-tested support level, providing some technical context around the announcement.

this person other insiders at GDRX

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 10, 2026

BILL Draws Investor Interest Among Texas & Florida Software Plays. Investors are monitoring BILL as part of a group of Texas and Florida software companies gaining attention. The stock sits near a 50‑level RSI and has recently touched its 200‑day moving average, while a support level at $47.26 has been tested multiple times. Analysts have a wide target range, and the company’s valuation is high relative to earnings. These factors may influence trading activity in the coming days.

this person other insiders at BILL

Transaction History

GDRX▲ Buy$0
GDRX▲ Buy—
GDRX▲ Buy$0
GDRX▲ Buy$0
GDRX▼ Sell$0
GDRX▼ Sell$0
GDRX▼ Sell$0
GDRX▲ Buy$0
GDRX▲ Buy$0
GDRX▼ Sell$176K
GDRX▲ Buy—
BILL▲ Buy—
GDRX▲ Buy—
GDRX▼ Sell$180K
GDRX▼ Sell$252K
GDRX▲ Buy—
BILL▲ Buy—
GDRX▼ Sell$276K
GDRX▲ Buy—
GDRX▲ Buy—
GDRX▼ Sell$308K
GDRX▲ Buy—
GDRX▼ Sell$280K
GDRX▲ Buy—
GDRX▼ Sell$306K
GDRX▲ Buy—
GDRX▼ Sell$190K
BILL▲ Buy—
GDRX▲ Buy$125K
GDRX▲ Buy$155K
GDRX▲ Buy$25K
GDRX▲ Buy$140K
GDRX▲ Buy$537K
BILL▲ Buy$508K
BILL▲ Buy—
BILL▲ Buy—

We use analytics to understand how market-wall is used. No personal data is sold.